Question: Has this approved drug been withdrawn due to toxicity reasons for all indications, populations, and doses in at least one country (not necessarily the US)?
Constraint: The Compound can be represented with the SMILES Br.CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21.
Answer: No
{#Question|Q!}: {quest#}
{#Constraint:|Description:|!} The {#Molecule|Compound|Chemical!} {#has the|can be represented with the!} {SMILES__description} {SMILES#}.
{#Answer|Result|Answer!}: {answ#}
Br.CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21
Br.CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-2-benzofuran-5-carbonitrile;hydrobromide
Has this approved drug been withdrawn due to toxicity reasons for all indications, populations, and doses in at least one country (not necessarily the US)?
No